# Salk Institute for Biological Studies

Salk Institute for Biological Studies is an Endowment / Foundation based in La Jolla, United States.

## Overview

- **Organization type:** Endowment / Foundation
- **Headquarters:** La Jolla, United States
- **Region:** North America
- **Address:** 10010 North Torrey Pines Rd, La Jolla, CA 92037, United States
- **Founded:** 1960
- **Assets under management:** 620 (Altss estimate)
- **Website:** salk.edu
- **LinkedIn:** https://www.linkedin.com/company/salk-institute-for-biological-studies

## Regulatory record

- **Reports private funds:** No

## About

The Salk Institute for Biological Studies was established in 1960 by Jonas Salk, the developer of the polio vaccine. It functions as an independent nonprofit research institute with an endowment that finances fundamental scientific work. The structure separates research operations from commercial development, relying on the endowment and external grants. The institute allocates roughly 24 percent of its portfolio to private equity alongside public market holdings. Confirmed positions include licensing and patent relationships with BridgeBio Pharma and Ipsen. Geographic exposure centers on the United States with additional research collaborations in Europe. Capital supports both early-stage biotechnology projects and later-stage pharmaceutical partnerships. The organization employs 1,256 people and maintains its headquarters on the original La Jolla campus. Adjacent assets include the Salk Institute Campus and 27 acres of coastal land. No material operational changes to the endowment or board leadership occurred in the last 24 months. The institute's architecture separates the 501(c)(3) research entity from its endowment management, with board oversight provided by trustees drawn from technology and finance backgrounds.

## Sectors

- Biotechnology
- Healthcare

## People

- Marna C. Whittington — Chair of the Board of Trustees
- Jonas Salk — Founder

## Questions

### Who runs investment decisions at Salk Institute for Biological Studies?

The board of trustees, chaired by Marna C. Whittington, oversees endowment policy. Day-to-day management draws on external advisors for public and private allocations.

### Does Salk Institute for Biological Studies participate in fund commitments or only direct deals?

The endowment holds both marketable securities and private equity exposure. Direct relationships appear through licensing and joint patent arrangements rather than broad fund commitments.

### What investment stages does Salk Institute for Biological Studies typically target?

Holdings span early-stage biotechnology through later-stage pharmaceutical collaborations. The 24 percent private equity allocation includes both venture and buyout exposure.

### How is Salk Institute for Biological Studies related to its founder?

Jonas Salk established the institute in 1960. Current governance rests with the board of trustees rather than direct family control.

## Related profiles

- [Foncer](https://altss.com/profile/foncer)
- [Local 817 IBT Pension Fund](https://altss.com/profile/local-817-ibt-pension-fund)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/salk-institute-for-biological-studies

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology